drugset / Trial / NCT02264535
A Pilot Study for Ginkgolides Meglumine Injection Skin Testing.
Phase 4
Completed
149 enrolled
Jiangsu Kanion Pharmaceutical Co., Ltd
Beijing Bionovo Medicine Development Co., Ltd. · collab
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
This pilot study is designed to explore the optimal concentration and method of Ginkgolides Meglumine Injection skin testing and to evaluate the value of skin test in predicting any possible allergic reactions to Ginkgolides Meglumine Injection.
Timeline
- Start
- 2014-06
- Primary completion
- 2014-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ginkgolides Meglumine | Unknown | 0.1 mg/ml | Other |
| Subject | Ginkgolides Meglumine | Unknown | 1 mg/ml | Other |
| Subject | Ginkgolides Meglumine | Unknown | 5 mg/ml | Other |